Microbicides for the Treatment of Sexually Transmitted HIV InfectionsReport as inadecuate

Microbicides for the Treatment of Sexually Transmitted HIV Infections - Download this document for free, or read online. Document in PDF available to download.

Journal of Pharmaceutics - Volume 2014 2014, Article ID 352425, 18 pages -

Review ArticleDepartment of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab 142001, India

Received 15 November 2013; Revised 20 December 2013; Accepted 26 December 2013; Published 12 February 2014

Academic Editor: Susana Zacchino

Copyright © 2014 Onkar Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Approximately 34 million people were living with human immunodeficiency virus HIV-1 at the end of 2011. From the last two decades, researchers are actively involved in the development of an effective HIV-1 treatment, but the results intended are still doubtful about the eradication of HIV. The HIV-1 virus has gone from being an “inherently untreatable” infectious agent to the one liable to be affected by a range of approved therapies. Candidate microbicides have been developed to target specific steps in the process of viral transmission. Microbicides are self-administered agents that can be applied to vaginal or rectal mucosal surfaces with the aim of preventing, or reducing, the transmission of sexually transmitted infections STIs including HIV-1. The development of efficient, widely available, and low-cost microbicides to prevent sexually transmitted HIV infections should be given high priority. In this review, we studied the various forms of microbicides, their mechanism of action, and their abundant approaches to control the transmission of sexually transmitted infections STIs.

Author: Onkar Singh, Tarun Garg, Goutam Rath, and Amit K. Goyal

Source: https://www.hindawi.com/


Related documents